Ubs Group Ag Immuno Precise Antibodies Ltd. Transaction History

Ubs Group Ag

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.98 - $1.53 $9,558 - $14,923	9,754 Added 393.62%	12,232 $12,000
Q1 2024 May 13, 2024	SELL	$1.4 - $2.41 $11,482 - $19,766	-8,202 Reduced 76.8%	2,478 $3,000
Q4 2023 Feb 09, 2024	BUY	$1.11 - $2.3 $11,777 - $24,402	10,610 Added 15157.14%	10,680 $18,000
Q3 2023 Nov 09, 2023	BUY	$1.76 - $3.04 $123 - $212	70 New	70 $0
Q4 2022 Feb 08, 2023	BUY	$4.5 - $5.72 $7,006 - $8,906	1,557 Added 5190.0%	1,587 $8,000
Q3 2022 Nov 10, 2022	SELL	$3.77 - $6.39 $13,440 - $22,780	-3,565 Reduced 99.17%	30 $0
Q2 2022 Aug 10, 2022	BUY	$3.8 - $6.08 $13,661 - $21,857	3,595 New	3,595 $14,000
Q1 2022 May 16, 2022	SELL	$3.64 - $6.49 $14,509 - $25,869	-3,986 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.06 - $6.69 $4,984 - $6,589	985 Added 32.82%	3,986 $21,000
Q3 2021 Nov 15, 2021	BUY	$5.14 - $13.22 $128 - $330	25 Added 0.84%	3,001 $18,000
Q2 2021 Aug 13, 2021	BUY	$6.02 - $12.91 $10,498 - $22,515	1,744 Added 141.56%	2,976 $18,000
Q1 2021 May 12, 2021	BUY	$8.84 - $17.0 $10,890 - $20,944	1,232 New	1,232 $12,000

1.9M

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $10.2M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.